• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1163 Show All Page 3 of 24
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1063
Weissella cibaria CMU Apr 14, 2023 FDA has no questions (in PDF) (254 kB)
  1062
Saccharomyces cerevisiae strain OYR-185 Apr 5, 2023 FDA has no questions (in PDF) (214 kB)
  1061
Deactivated alkaline serine protease produced by Bacillus licheniformis strain CICC 10266 Pending
  1060
2'-fucosyllactose Apr 4, 2023 FDA has no questions (in PDF) (333 kB)
  1059
Lacto-N-neotetraose Dec 2, 2022 FDA has no questions (in PDF) (288 kB)
  1058
Polyvinyl alcohol Jun 9, 2023 FDA has no questions (in PDF) (283 kB)
  1057
D-psicose Jan 25, 2024 FDA has no questions (in PDF) (298 kB)
  1056
β-lactoglobulin produced by Komagataella phaffii strain yRMK-66 Feb 15, 2023 FDA Has No Questions (in PDF) (291 kB)
  1055
Xylanase enzyme preparation produced by Bacillus licheniformis strain expressing the xylanase gene from Chryseobacterium Apr 4, 2023 FDA Has No Questions (in PDF) (265 kB)
  1054
Glucose oxidase enzyme preparation produced by Aspergillus niger expressing the gene encoding glucose oxidase from A. niger Jul 14, 2023 FDA has no questions (in PDF) (270 kB)
  1053
6'-sialyllactose sodium salt May 12, 2023 FDA Has No Questions (in PDF) (266 kB)
  1052
3'-sialyllactose sodium salt Apr 18, 2023 FDA has no questions (in PDF) (292 kB)
  1051
2'-fucosyllactose Nov 21, 2023 FDA has no questions (in PDF) (298 kB)
  1050
High 2-palmitic acid vegetable oil Jul 18, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (175 kB)
  1049
Medium-chain triacylglycerols Sep 21, 2022 FDA has no questions (in PDF) (249 kB)
  1048
Aminopeptidase enzyme preparation produced by Trichoderma reesei expressing a gene encoding an aminopeptidase from Aspergillus clavatus Pending
  1047
Lipase enzyme preparation produced by Saccharomyces cerevisiae expressing a gene encoding a lipase from Fusarium oxysporum Pending
  1046
Collagenase enzyme preparation from genetically modified Streptomyces violaceoruber expressing a collagenase gene Jun 22, 2023 FDA has no questions (in PDF) (219 kB)
  1045
Resistant dextrin from tapioca Aug 26, 2022 FDA has no Questions (in PDF) (250 kB)
  1044
Calcium disodium ethylenediaminetetraacetic acid May 25, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (118 kB)
  1043
Cetylated fatty acids Oct 26, 2022 FDA has no Questions (in PDF) (187 kB)
  1042
Menaquinone-7 derived from a specific strain of Bacillus subtilis natto Apr 3, 2023 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (188 kB)
  1041
Dry whole milk May 10, 2022 FDA has no questions (in PDF) (2.0 MB)
  1040
2'-fucosyllactose Sep 22, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (116 kB)
  1039
Lactase enzyme preparation produced by Aspergillus oryzae Pending
  1038
Preparation containing six bacteriophages (phage) specific to Salmonella enterica spp. serovars May 11, 2023 FDA has no questions (in PDF) (333 kB)
  1037
3-fucosyllactose Nov 7, 2022 FDA has no questions (in PDF) (287 kB)
  1036
Complexation products of iron with sodium citrate Oct 6, 2022 FDA Has No Questions (in PDF) (285 kB)
  1035
Lacto-N-fucopentaose I with 2'-fucosyllactose Jan 19, 2023 FDA has no questions (in PDF) (288 kB) Mar 1, 2023
  1034
2'-fucosyllactose Oct 21, 2022 FDA has no questions (in PDF) (258 kB)
  1033
Hydrolyzed Saccharomyces cerevisiae Pending
  1032
D-β-hydroxybutyrate Jun 2, 2022 FDA has no questions (in PDF) (214 kB)
  1031
Barley and rice protein hydrolysate Oct 20, 2022 FDA has no questions (in PDF) (219 kB)
  1030
Cellulase enzyme preparation produced by Aspergillus niger genetically engineered to express a cellulase gene from Trichoderma reesei Feb 15, 2023 FDA has no questions (in PDF) (286 kB)
  1029
D-psicose Aug 4, 2023 FDA has no questions (in PDF) (255 kB)
  1028
Metschnikowia pulcherrima DANMET-A and M. fructicola DANMET-B Pending
  1027
Miracle fruit (Synsepalum dulcificum) powder Dec 22, 2021 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (137 kB)
  1026
Silk fibroin derived from Bombyx mori cocoons Aug 11, 2022 FDA has no questions (in PDF) (185 kB)
  1025
Pepsin A enzyme preparation produced by Pichia pastoris to overexpress the gene encoding pepsin A Jan 6, 2023 FDA Has No Questions (in PDF) (318 kB)
  1024
D-psicose Mar 2, 2023 FDA Has no Questions (in PDF) (253 kB)
  1023
Monosodium L-5-methyltetrahydrofolate Jan 25, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (85 kB)
  1022
Streptococcus salivarius DB-B5 Aug 22, 2022 FDA has no questions (in PDF) (177 kB)
  1021
Transglutaminase enzyme preparation produced by Streptomyces mobaraensis strain M2020197 Nov 3, 2022 FDA has no questions (in PDF) (395 kB)
  1020
Protein from Helianthus annuus (sunflower protein) Jun 14, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (101 kB)
  1019
Agave mixed fructans from Agave tequilana Weber var. azul Feb 27, 2023 FDA has no questions (in PDF) (271 kB)
  1018
Carbon monoxide Aug 11, 2022 FDA has no questions (in PDF) (254 kB)
  1017
Lacto-N-tetraose Aug 23, 2022 FDA has no questions (in PDF) (245 kB)
  1016
6'-sialyllactose sodium salt Jul 15, 2022 FDA has no questions (in PDF) (237 kB)
  1015
3'-sialyllactose sodium salt Jul 15, 2022 FDA has no questions (in PDF) (234 kB)
  1014
2-fucosyllactose Jul 15, 2022 FDA has no questions (in PDF) (295 kB)

Show All 

jump to page of 24 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-